We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Quantification of human immunodeficiency virus type 1 tat mRNA as a marker for assessing the efficacy of antiretroviral therapy.
- Authors
Furtado, Manohar R.; Murphy, Robert; Wolinsky, Steven M.; Furtado, M R; Murphy, R; Wolinsky, S M
- Abstract
To evaluate the use of human immunodeficiency virus type 1 (HIV-1) tat mRNA quantification as a marker for antiretroviral therapy, 10 zidovudine-naive, p24 antibody-positive subjects (Centers for Disease Control classes III and IV) were studied at the start of zidovudine treatment. HIV-1 proviral DNA content and tat mRNA levels were monitored for 20 weeks from the initiation of therapy. Levels of tat mRNA were quantified using an engineered tat cRNA internal control under conditions of linear amplification. Proviral DNA levels increased in 2 patients and decreased in 8 during 20 weeks of therapy. In each case, tat mRNA levels exhibited similar but much more pronounced changes. Results indicate that quantitative measurement of tat mRNA levels is extremely useful for monitoring antiretroviral therapy.
- Publication
Journal of Infectious Diseases, 1993, Vol 167, Issue 1, p213
- ISSN
0022-1899
- Publication type
journal article
- DOI
10.1093/infdis/167.1.213